Anderson; Darrell R.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Anderson; Darrell R..The latest application filed is for "identification of unique binding interactions between certain antibodies and the human b7.1 and b7.2 co-stimulatory antigens".

Company Profile

0.22.19

Anderson; Darrell R. - Escondido CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Expression and use of anti-CD20 Antibodies Grant 7,744,877 - Anderson , et al. June 29, 2	2010-06-29
Identification Of Unique Binding Interactions Between Certain Antibodies And The Human B7.1 And B7.2 Co-stimulatory Antigens App 20090124791 - Anderson; Darrell R. ; et al.	2009-05-14
Methods of inducing immunosuppression by administering 7C10 and 16C10 CD80-specific antibodies Grant 7,510,713 - Anderson , et al. March 31, 2	2009-03-31
Methods of treating rheumatoid arthritis with 7C10 and 16C10 CD80-specific antibodies Grant 7,510,712 - Anderson , et al. March 31, 2	2009-03-31
Methods of producing 7C10 and 16C10 CD80-specific antibodies Grant 7,501,264 - Anderson , et al. March 10, 2	2009-03-10
Methods of inhibiting IL-2 production by T cells by administering 7C10 and 16C10 CD80-specific antibodies Grant 7,491,393 - Anderson , et al. February 17, 2	2009-02-17
Identification Of Unique Binding Interactions Between Certain Antibodies And The Human B7.1 And B7.2 Co-stimulatory Antigens App 20090012271 - Anderson; Darrell R. ; et al.	2009-01-08
Identification Of Unique Binding Interactions Between Certain Antibodies And The Human B7.1 And B7.2 Co-stimulatory Antigens App 20090010939 - Anderson; Darrell R. ; et al.	2009-01-08
Host cells expressing 7C10 and 16C10 CD80-specific antibodies Grant 7,425,447 - Anderson , et al. September 16, 2	2008-09-16
Anti-CD20 antibodies Grant 7,422,739 - Anderson , et al. September 9, 2	2008-09-09
7C10 and 16C10 CD80-specific antibodies Grant 7,417,128 - Anderson , et al. August 26, 2	2008-08-26
Nucleic acids encoding 7C10 and 16C10 CD80-specific antibodies Grant 7,414,123 - Anderson , et al. August 19, 2	2008-08-19
Expression and use of anti-CD20 antibodies Grant 7,381,560 - Anderson , et al. June 3, 2	2008-06-03
Identification Of Unique Binding Interactions Between Certain Antibodies And The Human B7.1 And B7.2 Co-stimulatory Antigens App 20080114156 - Anderson; Darrell R. ; et al.	2008-05-15
Identification Of Unique Binding Interactions Between Certain Antibodies And The Human B7.1 And B7.2 Co-stimulatory Antigens App 20080095769 - Anderson; Darrell R. ; et al.	2008-04-24
Therapeutic Application Of Chimeric And Radiolabelled Antibodies To Human B Lymphocyte Restricted Differentiation Antigen For Treatment Of B Cell Lymphoma App 20080089893 - Anderson; Darrell R. ; et al.	2008-04-17
Identification of Unique Binding Interactions Between Certain Antibodies and the Human B7.1 and B7.2 Co-Stimulatory Antigens App 20080038254 - Anderson; Darrell R. ; et al.	2008-02-14
Anti-CD80 antibodies Grant 7,323,170 - Anderson , et al. January 29, 2	2008-01-29
Identification Of Unique Binding Interactions Between Certain Antibodies And The Human B7.1 And B7.2 Co-stimulatory Antigens App 20070128185 - Anderson; Darrell R. ; et al.	2007-06-07
CD80 specific antibodies Grant 7,192,585 - Anderson , et al. March 20, 2	2007-03-20
Treating intestinal inflammation with anti-CD80 antibodies that do not inhibit CD80 binding to CTLA-4 Grant 7,175,847 - Anderson , et al. February 13, 2	2007-02-13
Treatment of B cell lymphoma using anti-CD80 antibodies that do not inhibit the binding of CD80 to CTLA-4 Grant 7,153,508 - Anderson , et al. December 26, 2	2006-12-26
Identification of Unique Binding Interactions Between Certain Antibodies and the Human B7.1 and B7.2 Co-Stimulatory Antigens App 20060275291 - Anderson; Darrell R. ; et al.	2006-12-07
Identification of unique binding interactions between certain antibodies and the human B7.1 and B7.2 co-stimulatory antigens and therapy thereof App 20050260205 - Anderson, Darrell R. ; et al.	2005-11-24
Therapeutic application of chimeric and radiolabeled antibodies to human B Lymphocyte restricted differentiation antigen for treatment of B cell Lymphoma App 20050186205 - Anderson, Darrell R. ; et al.	2005-08-25
Monkey monoclonal antibodies specific to human B7.1 and/or B7.2 primatized forms thereof, pharmaceutical compositions containing, and use thereof as immunosuppressants App 20050129688 - Anderson, Darrell R. ; et al.	2005-06-16
Methods for treating b cell lymphoma using CD80-specific antibodies Grant 6,893,638 - Anderson , et al. May 17, 2	2005-05-17
Treatment of psoriasis using anti-B7.1 (CD80) antibodies Grant 6,709,654 - Anderson , et al. March 23, 2	2004-03-23
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma Grant 6,682,734 - Anderson , et al. January 27, 2	2004-01-27
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma App 20030147885 - Anderson, Darrell R. ; et al.	2003-08-07
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restriced differentiation antigen for treatment of B cell lymphoma App 20030095963 - Anderson, Darrell R. ; et al.	2003-05-22
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma App 20030082172 - Anderson, Darrell R. ; et al.	2003-05-01
Therapeutic application of chimeric and radiolabelled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma App 20030021781 - Anderson, Darrell R. ; et al.	2003-01-30
Therapeutic application of chimeric and radiolabelled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma App 20020197255 - Anderson, Darrell R. ; et al.	2002-12-26
Identification of unique binding interactions between certain antibodies and the human B7.1 and B7.2 co-stimulatory antigens App 20020187146 - Anderson, Darrell R. ; et al.	2002-12-12
Chimeric and radiolabelled antibodies specific to human CD20 antigen and use thereof for treatment of B-cell lymphoma Grant 6,399,061 - Anderson , et al. June 4, 2	2002-06-04
Monkey monoclonal antibodies specific to human B7.1 and/or B7.2, primatized forms thereof, pharmaceutical compositions containing, and use thereof as immunosuppressants App 20010024648 - Anderson, Darrell R. ; et al.	2001-09-27
Human B7.1-specific primatized antibodies and transfectomas expressing said antibodies Grant 6,113,898 - Anderson , et al. September 5, 2	2000-09-05
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma Grant 5,843,439 - Anderson , et al. December 1, 1	1998-12-01
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma Grant 5,776,456 - Anderson , et al. July 7, 1	1998-07-07
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma Grant 5,736,137 - Anderson , et al. April 7, 1	1998-04-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.